Literature DB >> 25496815

Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.

Arne Kandulski1, Jochen Weigt2, Carlos Caro2, Doerthe Jechorek3, Thomas Wex4, Peter Malfertheiner2.   

Abstract

BACKGROUND & AIMS: Mucosal integrity can be assessed in patients with gastroesophageal reflux disease (GERD) by measuring intraluminal baseline impedance (BI). However, it is not clear whether BI is abnormal in patients with functional heartburn (FH), or can be used to distinguish them from patients with GERD. We compared differences in BI between patients with FH vs GERD.
METHODS: We performed a prospective study of 52 patients (16 men; mean age, 55 y; range, 23-78 y) seen at a tertiary university hospital from February 2009 through December 2012. Thirty-five patients had GERD (19 had nonerosive reflux disease [NERD], 16 had erosive reflux disease [ERD]) and 17 had FH. All patients discontinued proton pump inhibitor therapy and then underwent esophagogastroduodenoscopy and multichannel intraluminal impedance and pH monitoring. BI was assessed at 3, 5, 7, 9, 15, and 17 cm proximal to the lower esophageal sphincter in recumbent patients. Biopsy specimens were taken from 3 cm above the gastroesophageal junction; histology analysis was performed to identify and semiquantitatively score (scale, 0-3) dilated intercellular spaces.
RESULTS: Baseline impedance in the distal esophagus was significantly lower in patients with NERD or erosive reflux disease (ERD) than FH (P = .0006). At a cut-off value of less than 2100 Ω, BI measurements identified patients with GERD with 78% sensitivity and 71% specificity, with positive and negative predictive values of 75%. Also in the proximal esophagus, reduced levels of BI levels were found only in patients with ERD. There were negative correlations between level of BI and acid exposure time (r = -0.45; P = .0008), number of acidic reflux episodes (r = -0.45; P = .001), and proximal extent (r = -0.40; P = .004). Biopsy specimens from patients with NERD or ERD had significant increases in dilation of intercellular spaces, compared with those from patients with FH; there was an inverse association between dilated intercellular spaces and BI in the distal esophagus (r = -0.28; P = .06).
CONCLUSIONS: Measurement of BI in the lower esophagus can differentiate patients with ERD or NERD from patients with FH (78% sensitivity and 71% specificity), and therefore should be considered as a diagnostic tool for patients with proton pump inhibitor-refractory reflux. Low levels of BI are associated with increased exposure to acid and dilation of intercellular spaces, indicating that BI is a marker of mucosal integrity.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acid-Suppressive Therapy; Diagnosis; Esophageal Mucosa; MII-pH

Mesh:

Year:  2014        PMID: 25496815     DOI: 10.1016/j.cgh.2014.11.033

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  39 in total

Review 1.  Advances in the Diagnosis and Treatment of GERD: New Tricks for an Old Disease.

Authors:  Rishi D Naik; Lauren Evers; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

Review 2.  Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments.

Authors:  Kornilia Nikaki; Philip Woodland; Daniel Sifrim
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-27       Impact factor: 46.802

Review 3.  Esophageal Impedance Monitoring: Clinical Pearls and Pitfalls.

Authors:  Karthik Ravi; David A Katzka
Journal:  Am J Gastroenterol       Date:  2016-06-21       Impact factor: 10.864

4.  Lower oesophageal sphincter identification for gastro-oesophageal reflux monitoring: The step-up method revisited with use of basal impedance.

Authors:  Aurelio Mauro; Marianna Franchina; Dario Consonni; Roberto Penagini
Journal:  United European Gastroenterol J       Date:  2019-06-17       Impact factor: 4.623

Review 5.  Expert consensus document: Advances in the physiological assessment and diagnosis of GERD.

Authors:  Edoardo Savarino; Albert J Bredenoord; Mark Fox; John E Pandolfino; Sabine Roman; C Prakash Gyawali
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-27       Impact factor: 46.802

Review 6.  Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.

Authors:  Rena Yadlapati; Kelli DeLay
Journal:  Med Clin North Am       Date:  2018-11-01       Impact factor: 5.456

7.  Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease.

Authors:  A Patel; D Wang; N Sainani; G S Sayuk; C P Gyawali
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

8.  Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.

Authors:  A Patel; G S Sayuk; C P Gyawali
Journal:  Neurogastroenterol Motil       Date:  2016-04-08       Impact factor: 3.598

9.  Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.

Authors:  Kerry B Dunbar; Agoston T Agoston; Robert D Odze; Xiaofang Huo; Thai H Pham; Daisha J Cipher; Donald O Castell; Robert M Genta; Rhonda F Souza; Stuart J Spechler
Journal:  JAMA       Date:  2016-05-17       Impact factor: 56.272

Review 10.  Biomarkers of Reflux Disease.

Authors:  Leila Kia; John E Pandolfino; Peter J Kahrilas
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.